查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1791490

全球人工器官及仿生学市场

Artificial Organs and Bionics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球人工器官和仿生学市场规模将达到 710 亿美元

全球人工器官和仿生学市场规模预计在2024年达到432亿美元，预计2024年至2030年期间的复合年增长率为8.6%，到2030年将达到710亿美元。人工器官是本报告分析的细分市场之一，预计其复合年增长率将达到10.0%，到分析期结束时规模将达到451亿美元。人工仿生学细分市场在分析期间的复合年增长率预计为6.4%。

美国市场预计将达到 114 亿美元，中国市场复合年增长率将达到 8.3%

美国人工器官和仿生学市场规模预计在2024年达到114亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到113亿美元，在2024-2030年的分析期间内，复合年增长率为8.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为8.1%和7.1%。在欧洲，预计德国市场的复合年增长率约为6.7%。

全球人工器官和仿生学市场—主要趋势和驱动因素摘要

人造器官和仿生学如何重新定义人类的寿命和功能？

人工器官和仿生技术正在彻底改变现代医疗格局，为器官衰竭或身体功能丧失的患者提供挽救生命和改善生活的替代方案。从人工心臟和肾臟到人工电子耳和仿生肢体，该领域将生物医学工程与机器人技术、电子技术和先进材料融为一体。人工器官是器官移植的关键桥樑，也是器官捐赠者持续短缺时的长期解决方案。同时，仿生技术可以恢復运动、听力和视力，使患者重新获得独立生活和生活品质。这些技术创新对于慢性病猖獗的老化社会尤其重要。神经介面、触觉回馈和即时监控的整合使现代仿生技术比以往任何时候都更加灵敏和逼真。用于截瘫患者復健和行动的外骨骼以及3D列印器官支架正在突破以前被认为不可能实现的极限。微型化、电池寿命和植入式生物感测器的不断改进正在创造更智慧、更适合患者的设备。这种学科融合正在推动医疗保健走向未来，届时残疾不再是永久性的限制，器官衰竭不再是死刑。

哪些技术突破正在加速该领域的创新？

再生医学、生医材料、人工智慧诊断和机器人技术的突破推动了人造器官和仿生学的创新。生物列印技术正在创建模拟自然组织特性的血管化器官结构。组织工程的进步现在允许将实验室培育的皮肤、角膜甚至软骨与人造植入整合。由脑机介面 (BMI) 驱动的神经连接义肢可以透过思想实现直观控制，为截肢者和脊髓损伤患者开闢了新的可能性。义肢中嵌入的感测器提供即时回馈，例如握力和表面纹理，从而显着改善使用者体验。在人工心臟和辅助人工心臟中，磁浮转子和节能马达提高了安全性并延长了装置的使用寿命。碳纤维复合材料和基于人工智慧的运动模式识别正在使穿戴式仿生设备（包括动力服装）更轻、更实惠。奈米涂层和抗菌表面可提高植入的生物相容性，并降低感染风险。随着机器学习演算法日益复杂，它们将能够动态调整胰岛素帮浦、起搏器和肾臟辅助装置，从而提供个人化性能，并带来医疗保健方面的预测性洞察。

社会、道德和经济因素会影响市场趋势吗？

随着人工器官和仿生学市场日趋成熟，其发展轨迹日益受到社会接受度、伦理争议和报销政策的影响。随着仿生肢体和人工胰腺系统的成功案例出现在主流媒体，社会意识正在不断提升，但关于人类增强、身份认同和可及性的伦理问题仍然存在。修復和增强之间的界限日益模糊，引发了关于「正常」健康定义的争论。成本仍然是一个重大障碍，尤其是在发展中地区，这些地区获得先进义肢和植入式设备的管道仍然有限。儘管许多国家医疗保险体系面临着为这些昂贵技术提供更大覆盖范围的压力，但预算限制仍然存在。此外，缺乏训练有素的专业人员来处理复杂的仿生系统，尤其是在移植后復健方面。全球医疗保健差距正在影响这些技术的应用范围和方式。同时，患者权益组织呼吁加速救生设备的监管核准。儘管政府和非政府组织为研究提供资金和补贴的努力正在取得进展，但其广泛应用仍然是一项挑战。在创新、道德和可负担性之间取得平衡可能是充分发挥这一转变潜力的关键。

人工器官和仿生学市场的成长受到多种因素的推动。

慢性病和退化性疾病发生率上升、全球器官捐赠者短缺以及医疗技术创新投资增加，推动了对肾臟替代疗法、心血管植入和助听器的需求。全球老化，尤其是欧洲和日本的老化，导致对肾臟替代疗法、心血管植入物和助听器的需求激增。技术进步使这些设备更加精确、紧凑和可靠，从而刺激了医疗保健提供者对其的采用。在新兴市场，医疗基础设施的改善和保险覆盖范围的扩大正在推动市场渗透。在復健领域，医疗和军事部门对穿戴式仿生外骨骼的需求都在增加。消费者行为也在发生变化，患者越来越了解情况，并且愿意采用能够改善其生活方式和自主性的身体整合技术。在高所得市场中，选择性使用仿生解决方案来增强行动性和功能性也正在兴起。医疗机构和高科技公司之间的研究合作正在加速原型製作、测试和商业化。新的模式正在利用云端基础的健康数据整合来实现远端监控和预测性护理，这使得它们对远端医疗平台特别有吸引力。在监管支援和强大的创新管道的支持下，这些趋势正在巩固市场的上升趋势。

部分

产品类型（人工器官、人工仿生）；技术（机械仿生技术、电子仿生技术）

受访公司范例

  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Berlin Heart GmbH
  • Bornlife Prosthetic and Orthotic Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics Holdings Inc.
  • Getinge AB（Getinge Group）
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • Ossur
  • Sonova
  • SynCardia Systems, LLC
  • Zimmer Biomet Holdings, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP29287

Global Artificial Organs and Bionics Market to Reach US$71.0 Billion by 2030

The global market for Artificial Organs and Bionics estimated at US$43.2 Billion in the year 2024, is expected to reach US$71.0 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Artificial Organs, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$45.1 Billion by the end of the analysis period. Growth in the Artificial Bionics segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.4 Billion While China is Forecast to Grow at 8.3% CAGR

The Artificial Organs and Bionics market in the U.S. is estimated at US$11.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global "Artificial Organs And Bionics" Market - Key Trends & Drivers Summarized

How Are Artificial Organs And Bionics Redefining Human Longevity And Functionality?

Artificial organs and bionics are revolutionizing the landscape of modern medicine by offering life-saving and life-enhancing alternatives for patients with failing organs or lost bodily functions. From artificial hearts and kidneys to cochlear implants and bionic limbs, this sector merges biomedical engineering with robotics, electronics, and advanced materials. Artificial organs serve as vital bridges to transplants or long-term solutions where donor shortages persist. Bionics, meanwhile, restore movement, hearing, or vision-enabling patients to regain independence and quality of life. These innovations are especially critical for aging populations, where chronic diseases are prevalent. The integration of neural interfaces, haptic feedback, and real-time monitoring has made modern bionics more responsive and lifelike than ever before. Exoskeletons for rehabilitation and mobility in paraplegic patients, as well as 3D-printed organ scaffolds, are pushing boundaries previously thought impossible. Continuous improvement in miniaturization, battery life, and implantable biosensors is creating smarter, more patient-adaptive devices. This convergence of disciplines is moving healthcare toward a future where disability is no longer a permanent limitation, and organ failure no longer a death sentence.

What Technological Breakthroughs Are Accelerating Innovation In This Field?

Innovation in artificial organs and bionics is being propelled by breakthroughs in regenerative medicine, biomaterials, AI-enabled diagnostics, and robotics. Bio-printing technologies are enabling the creation of vascularized organ structures that can mimic natural tissue properties. Advances in tissue engineering now allow lab-grown skin, corneas, and even cartilage to be integrated with synthetic implants. Neural-linked prosthetics, driven by brain-machine interfaces (BMIs), enable intuitive control through thought, opening new possibilities for amputees and spinal cord injury patients. Sensors embedded in prosthetic limbs provide real-time feedback, such as grip strength or surface texture, which significantly improves user experience. In artificial hearts and ventricular assist devices (VADs), magnetically levitated rotors and energy-efficient motors have enhanced safety and extended device longevity. Wearable bionics, including powered exosuits, are becoming lighter and more affordable thanks to carbon fiber composites and AI-based motion pattern recognition. Nanocoatings and antimicrobial surfaces are improving the biocompatibility of implants, reducing infection risks. As machine learning algorithms become more sophisticated, they are enabling dynamic adjustments in insulin pumps, pacemakers, and renal assist devices, offering personalized performance with predictive healthcare insights.

Are Societal, Ethical, And Economic Factors Influencing Market Trajectory?

As the artificial organ and bionics market matures, its trajectory is increasingly shaped by social acceptance, ethical debates, and reimbursement policies. Public perception is evolving as success stories of bionic limbs or artificial pancreas systems enter mainstream media, but ethical questions about human enhancement, identity, and access remain. The line between restoration and augmentation is blurring, leading to debates on what constitutes “normal” health. Cost remains a critical barrier, especially in developing regions, where access to advanced prosthetics and implantable devices is still limited. Health insurance systems in many countries are under pressure to cover more of these expensive technologies, yet budget constraints remain. There’s also a shortage of trained professionals to handle complex bionic systems, particularly in post-implantation rehabilitation. Global health disparities are influencing where and how these technologies are adopted. Meanwhile, patient advocacy groups are demanding faster regulatory approvals for life-saving devices. Efforts by governments and NGOs to fund research and offer subsidies are gaining momentum, but widespread accessibility remains a challenge. Balancing innovation, ethics, and affordability will be key to unlocking the full potential of this transformative sector.

The Growth In The Artificial Organs And Bionics Market Is Driven By Several Factors…

…including the rising prevalence of chronic and degenerative diseases, the global shortage of organ donors, and increasing investments in medical innovation. The aging global population, particularly in Europe and Japan, is contributing to a surge in demand for renal replacement therapies, cardiovascular implants, and hearing aids. Technological readiness has made these devices more accurate, compact, and reliable, encouraging adoption among healthcare providers. In emerging economies, rising healthcare infrastructure and growing insurance coverage are facilitating market penetration. The rehabilitation sector is expanding with demand for wearable bionic exoskeletons in both medical and military settings. Consumer behavior is shifting, too-patients are increasingly informed and open to adopting body-integrated technologies that enhance lifestyle and autonomy. In high-income markets, elective use of bionic solutions for athletic performance or functional enhancement is also emerging. Research collaborations between medical institutions and tech firms are leading to faster prototyping, testing, and commercialization. The availability of cloud-based health data integration in newer models allows remote monitoring and predictive care, which is particularly attractive to telemedicine platforms. These trends, underpinned by regulatory support and a strong innovation pipeline, are solidifying the market’s upward trajectory.

SCOPE OF STUDY:

The report analyzes the Artificial Organs and Bionics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Artificial Organs, Artificial Bionics); Technology (Mechanical Bionics Technology, Electronic Bionics Technology)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Berlin Heart GmbH
  • Bornlife Prosthetic and Orthotic Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics Holdings Inc.
  • Getinge AB (Getinge Group)
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • Ossur
  • Sonova
  • SynCardia Systems, LLC
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Organs and Bionics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Organ Failure Cases Drive Demand for Artificial Organs
    • Technological Innovations in Bionic Limbs Improve Mobility and Quality of Life
    • Increased Investment in 3D Bioprinting of Tissues Accelerates Market Expansion
    • Growing Use of Neural Interfaces in Bionics Enhances Functional Capabilities
    • Shortage of Organ Donors Boosts Development of Artificial Alternatives
    • Surging Demand for Wearable and Implantable Health Devices Fuels Bionic Integration
    • Advancements in Smart Prosthetics Offer Customization and Real-Time Feedback
    • Expanding Application in Military and Rehabilitation Drives Innovation
    • Insurance Coverage for Artificial Organs Encourages Patient Adoption
    • Emergence of Soft Robotics in Artificial Organ Development Improves Biocompatibility
    • AI-Driven Control Systems in Bionics Enhance Patient Outcomes
    • Growing Geriatric Population with Chronic Organ Diseases Supports Long-Term Growth
    • Cross-Sector Collaborations in Biotech and Engineering Foster Breakthroughs
    • Global Expansion of Transplant Centers and Medical Facilities Drives Market Reach
    • Increased Funding from Government and Private Institutions Spurs R&D Progress
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Organs and Bionics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Organs and Bionics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Artificial Bionics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Artificial Bionics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mechanical Bionics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Mechanical Bionics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Electronic Bionics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Electronic Bionics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 13: USA 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 14: USA Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: Canada 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Canada 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • JAPAN
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Japan 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • CHINA
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 24: China Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: China 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 26: China Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • EUROPE
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 28: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: Europe 6-Year Perspective for Artificial Organs and Bionics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Europe 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • FRANCE
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 34: France Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: France 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 36: France Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: France 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • GERMANY
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Germany 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • ITALY
    • TABLE 42: Italy Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Italy 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 46: UK Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: UK 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 48: UK Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: UK 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Asia-Pacific 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of World 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of World 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030

IV. COMPETITION